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ABSTRACT
Objective: The objective of this study was to study the in vitro-in vivo correlationship between the magnetic microspheres prepared by continuous 
solvent evaporation (CSE) method by 32 factorial designs.
Methods: CSE technique was used in the preparation of magnetic microspheres. Drug used was cytarabine and mice were the animal model used to 
check the correlationship.
Results: The profiles are nearly identical and reveal that drug absorption is rapid. The in vivo drug absorbed was found to be in concordance with the 
in vitro release as seen in the superimposable curves.
Conclusion: Cytarabine effectively reduces the amount of drug released and consequently absorbed in vivo in the initial phase.
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INTRODUCTION
Magnetic microspheres are the particles that are targeted to the 
desired site of action by the application of the magnetic field. These are 
mainly used for targeting in case of tumor sites; cytarabine is mainly 
used for leukemia. Leukemia is a cancer of the white blood cells and 
bone marrow. Magnetic microspheres were formulated by 32 factorial 
designs [1]. Thus, a formulation, that is, magnetic microspheres was 
prepared for cytarabine. In vitro-in vivo correlation (IVIVC) approach 
involves the comparison of the behavior of drug absorbed in vivo and 
its comparison for the profile in vitro. Thus, leukemia cases can be 
minimized by having an idea about IVIVC. Mice were the animal model 
used.
MATERIALS AND METHODS
Dosing and blood sample collection
Wistar strain of rats was used for the study. The protocol for performing 
experiment was approved by the Institutional Animal Ethical 
Committee as per the rules of Committee for the Purpose of Control 
and Supervision of Experiments on Animals, India. Animals were 
euthanized after accomplishment of the study and the carcasses were 
disposed as per the guidelines of the institute.
Blood samples (1 ml) were withdrawn from animals and collected 
directly in tubes containing 300 ml of sodium citrate solution (2% w/v). 
Blood samples were collected at predetermined time intervals that are 
0, 1, 2, 3, 4, 8, 9, and 10 h (seven time points).
The blood samples were centrifuged at 4000 revolutions/min (for 
10 min at 4°C); separated plasma samples were stored in clean screw 
capped polypropylene plasma tubes until further analysis.
Extraction of drug from plasma
About 0.5 ml plasma sample was taken in a centrifuge tube, and 
extraction was later on done with chloroform. After shaking for 1 min 
and then subjecting to centrifugation at 2000 rpm, all the three layers 
were separated. The separated layers were again mixed with chloroform 
0.5 ml and further subjected to centrifugation. The organic layer from 
all the three vials was collected. The collected organic layer was later 
on subjected to dryness on water bath. The residue was dissolved 
in methanol, 0.20 ml of aliquot was applied for HPLC (Kromasil C18 
column, 1.5 ml/min, ambient 50°C, retention time 8.5±0.03 min) [2,3].
Pharmacokinetic parameters and their statically evaluation
The highest observed plasma cytarabine concentration Cmax and the 
time to reach Cmax relative to the time of dosing (tmax) were noted from 
the plasma concentration versus time profile.
Plasma concentration of cytarabine and cytarabine magnetic 
microspheres at different time intervals was determined [4-8].
RESULTS AND DISCUSSION
Comparison of plasma concentration (ng/ml) obtained for cytarabine 
magnetic microspheres and cytarabine is shown in Fig. 1.
The relationship of observed drug concentration-time profiles 
following administration of microsphere with drug dissolution and 
pharmacokinetics can be described graphically (Fig. 2).
It is presumed that absorption and dissolution have a linear relationship; 
thus, absorption and dissolution features of a drug can be used 
interchangeably. Profiles of drugs can be established with dissolution 
profiles in combination with the pharmacokinetic characteristics of the 
drug. This method of attaining a drug profile from dissolution results 
is convolution. Extracting a dissolution profile from blood profile is 
deconvolution.
The mean peak plasma concentration of the drug was 103±10.14 ng/ml, 
while that of cytarabine magnetic microspheres were 110±21.13 ng/ml. 
This showed that magnetic microspheres of cytarabine effectively reduce 
the amount of drug released and consequently absorbed in vivo in the 
initial phase.
The relation between percentage drug released in vitro and the percent 
absorbed for magnetic microspheres was assessed using Wagner-Nelson 
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approach. The fraction absorbed (�abs) was determined from the 
plasma concentration-time data by deconvolution using the Nelson-
Wagner method.
�abs (�) = [�(�)+��×AUC(0−�)]/[��×AUC(0−inf)]
With the Nelson-Wagner equation, the pharmacokinetic profile is 
deconvoluted to obtain the in vivo absorption as a function of time and is 
plotted alongside the in vitro release data to assess the superimposability 
of the two profiles. If the two curves are superimposable and a linear 
relationship is obtained, it suggests a strong correlation between in vivo 
and in vitro drug release.
Once deconvoluted, the in vivo curve is plotted alongside the in vitro 
release data to assess the superimposability of the two profiles. Thus, 
the deconvolution approach allows comparison of in vivo release profile 
with in vitro behavior. The profiles are nearly identical and reveal that 
drug absorption is rapid. The in vivo drug absorbed was found to be 
in concordance with the in vitro release as seen in the superimposable 
curves.
Percentage release  in vivo  curves, using the Nelson-Wagner method, 
are nearly superimposable for the formulations. Nearly likely findings 
were reported by Chu et al. in a study on PLGA microspheres containing 
the alkaloid, Huperzine A.
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Fig. 1: Comparison of plasma concentration (ng/ml) obtained for 
cytarabine magnetic microspheres and cytarabine
Fig. 2: Comparison of drug released in vitro and absorbed drug 
in vivo
